Skip to content
Open access

A-114: Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Associations With Cognition, Gait Symptoms, and Diagnostic Cerebrospinal Fluid Removal Responsiveness

Oct 2026 · Archives of Clinical Neuropsychology · 0 citations

TL;DR

Co-morbid Alzheimer’s disease (AD) may influence symptom expression in idiopathic normal pressure hydrocephalus (iNPH) and whether iNPH symptoms and post-CSF removal gait responsiveness relate to CSF AD biomarkers is examined.

Abstract

Objective: Co-morbid Alzheimer’s disease (AD) may influence symptom expression in idiopathic normal pressure hydrocephalus (iNPH). Studies linking cerebrospinal fluid (CSF) AD biomarkers to iNPH symptoms are limited by small samples. We examined whether iNPH symptoms and post-CSF removal gait responsiveness relate to CSF AD biomarkers. Method/Data Selection: Patients with possible iNPH (n=194; Mage=75.68) underwent gait and neuropsychological assessment before and after large-volume CSF removal. Neuropsychological measures included: RBANS Digit Span, WAIS-IV Coding, FAS+Animals, Trail-Making (TMT), Hopkins Verbal Learning Test-Revised (HVLT-R), and a global neurocognitive index (GNI; average performance). Gait measures included: 10-Meter Walk Test (10MWT), Timed Up and Go (TUG)+Dual-Task (TUG-D), and Mini-Balance Evaluation Systems Test (MiniBEST). CSF amyloid beta-42 (Aβ-42), total-tau (t-tau), phosphorylated-tau (pTau181), and Aβ-42/pTau181 ratio were measured using Mayo ADEVL (ECLIA immunoassay). Controlling for age, Spearman’s correlations measured associations between biomarkers, cognition, and gait. Mann-Whitney U assessed biomarker differences between gait responders and non-responders determined by reliable change (Zchange>1.96 in ≥2 measures). Results/Data Synthesis: Aβ-42 correlated with GNI, digit span, coding, and HVLT-R learning (ρ’s=.31-.38; p’s.05) but weakly correlated (ρ=0.159-0.173; p’s<.05) with MiniBEST. Gait responders had higher Aβ-42 and lower Aβ-42/pTau ratio181 (rrbs=-.221; ps=.011). Conclusions: Aβ-42 had stronger associations with cognition than gait, while tau related modestly with gait. The presence of Aβ-42 had small associations with post-CSF removal gait responsiveness. Future work with expanded AD biomarker profiles in post-shunt follow-up may further elucidate these relationships.

Read PDF

Similar papers

Open access 2026

Cerebrospinal Fluid Neuroinflammatory Biomarkers and Motor Symptom Severity in Early-Stage Parkinson’s Disease: A Cross-Sectional Analysis of the PPMI Cohort

It is suggested that CSF neuroinflammatory biomarkers were not associated with early motor severity in this sample of early-stage PD patients, and future research should examine whether these markers are more closely associated with other domains such as cognitive decline.

Harshal Lingineni · 0 citations
Case report Open access Oct 2026

Case Report: Longitudinal evaluation of cerebrospinal fluid Alzheimer’s disease core biomarkers in a case of refractory late-onset epilepsy of unknown etiology

In recent years, late-onset epilepsy of unknown etiology (LOEU) has increasingly been recognized as a risk factor for Alzheimer’s disease (AD) and other forms of dementia. We present a case of refractory LOEU with progressive cognitive decline, longitudinally evaluated over more than 20 years using neuropsychological t...

Takafumi Wada, Akira Kuzuya, Kazuma Koda et al. · 0 citations
Open access Oct 2026

A-74: Neurocognitive and Clinical Correlates of Parkinson’s Disease and Parkinsonian Signs in a Pilot Aging Cohort

Objective: To characterize neurocognitive, sleep, lifetime activity, and exploratory diet and alcohol differences associated with Parkinson’s disease (PD) or parkinsonian signs in an aging cohort. Method/Data Selection: Participants were 105 adults 65+ who underwent dementia research evaluation at Mount Sinai and rec...

Catherine Kenney, Jessica Spat-lemus, Shreya Upendra et al. · 0 citations
Open access Sep 2026

Multimodal neuroimaging and electrophysiological signatures in amnestic mild cognitive impairment with different amyloid-β deposition status: correlations with cognitive function and diagnostic value

Background Amnestic mild cognitive impairment (aMCI) is a heterogeneous transitional cognitive state between normal aging and dementia. Aβ positivity elevates dementia conversion risk but does not equate to prodromal Alzheimer’s disease (AD), and not all Aβ-positive aMCI individuals progress to clinical AD dementia. Di...

Yan Liang, Pei-Xue Li, Lin Liu et al. · 0 citations
Open access Oct 2026

Cerebrospinal fluid surfactant protein-G in neurodegenerative dementia: A comparative study with idiopathic normal-pressure hydrocephalus

Background Surfactant protein G (SP-G) is a recently characterized protein potentially involved in cerebrospinal fluid (CSF) dynamics. Its role in human neurodegenerative dementia remains unknown. Objective To investigate the potential clinical relevance of CSF SP-G levels in neurodegenerative dementia (ND; including A...

Stefania Cattaldo, F. Scarpina, Elisa Prina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.